We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

96 hedge funds and large institutions have $455M invested in AMAG Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 96 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more call options, than puts

Call options by funds: $926K | Put options by funds: $296K

Holders
96
Holders Change
+96
Holders Change %
% of All Funds
3.13%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
96
Increased
Reduced
Closed
Calls
$926K
Puts
$296K
Net Calls
+$630K
Net Calls Change
+$630K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$90.9M +$90M +4,085,330 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$45.8M +$45.3M +2,057,888 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$45.4M +$44.9M +2,039,400 New
PAI
4
Palo Alto Investors
California
$37.4M +$37M +1,680,871 New
First Manhattan
5
First Manhattan
New York
$20.1M +$19.9M +904,764 New
BFA
6
BlackRock Fund Advisors
California
$20M +$19.8M +900,469 New
JP Morgan Chase
7
JP Morgan Chase
New York
$18.2M +$18M +816,520 New
CCM
8
Consonance Capital Management
New York
$16.4M +$16.2M +737,186 New
BIT
9
BlackRock Institutional Trust
California
$15.3M +$15.2M +689,660 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$13.8M +$13.7M +620,129 New
State Street
11
State Street
Massachusetts
$8.58M +$8.49M +385,389 New
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$7.98M +$7.91M +358,753 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$7.88M +$7.81M +354,230 New
IIM
14
Ironwood Investment Management
Massachusetts
$7.49M +$7.41M +336,504 New
Northern Trust
15
Northern Trust
Illinois
$7.17M +$7.1M +322,073 New
SONJCPFA
16
State of New Jersey Common Pension Fund A
New Jersey
$6.59M +$6.53M +296,167 New
KCM
17
Kennedy Capital Management
Missouri
$6.03M +$5.97M +271,028 New
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$5.99M +$5.93M +269,200 New
Charles Schwab
19
Charles Schwab
California
$5.77M +$5.69M +258,013 New
Norges Bank
20
Norges Bank
Norway
$4.1M +$4.06M +184,168 New
TA
21
Teachers Advisors
New York
$4.04M +$4M +181,510 New
QBFM
22
QS Batterymarch Financial Management
New York
$4M +$3.96M +179,720 New
BIM
23
Bogle Investment Management
Massachusetts
$3.47M +$3.44M +156,129 New
TCIM
24
TIAA CREF Investment Management
New York
$3.1M +$3.07M +139,256 New
RCAMU
25
Rothschild & Co Asset Management US
Connecticut
$2.98M +$2.95M +134,055 New

AMAG Hedge Fund Activity: Q2 2013 in Review

96 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q2 2013, worth a combined $455M.

Buyers outnumbered sellers: 96 funds opened new AMAG positions and 0 closed out — a net gain of 96 holders — while 0 added to existing stakes and 0 trimmed.

  • 96 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $455M of AMAG Pharmaceuticals stock for Q2 2013.
  • 96 funds opened new AMAG Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +96 holders.

Based on aggregated 13F filings for Q2 2013.